AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | 0.0% | 15,465 | +8.2% | 0.00% | – |
| Q2 2022 | $5,000 | -86.1% | 14,293 | -71.9% | 0.00% | – |
| Q1 2022 | $36,000 | -74.6% | 50,807 | -19.0% | 0.00% | – |
| Q4 2021 | $142,000 | -17.4% | 62,741 | +5.2% | 0.00% | – |
| Q3 2021 | $172,000 | -35.3% | 59,634 | -15.1% | 0.00% | -100.0% |
| Q2 2021 | $266,000 | +31.7% | 70,222 | +17.9% | 0.00% | 0.0% |
| Q1 2021 | $202,000 | +33.8% | 59,537 | +10.2% | 0.00% | 0.0% |
| Q4 2020 | $151,000 | +48.0% | 54,036 | +32.9% | 0.00% | – |
| Q3 2020 | $102,000 | -81.4% | 40,648 | +0.9% | 0.00% | -100.0% |
| Q2 2020 | $547,000 | +209.0% | 40,300 | +73.0% | 0.00% | +200.0% |
| Q1 2020 | $177,000 | -33.0% | 23,299 | -44.2% | 0.00% | 0.0% |
| Q4 2019 | $264,000 | +47.5% | 41,725 | -8.5% | 0.00% | 0.0% |
| Q3 2019 | $179,000 | -15.2% | 45,626 | +4.9% | 0.00% | 0.0% |
| Q2 2019 | $211,000 | -47.2% | 43,495 | -11.0% | 0.00% | -50.0% |
| Q1 2019 | $400,000 | +154.8% | 48,846 | +72.3% | 0.00% | +100.0% |
| Q4 2018 | $157,000 | -39.6% | 28,349 | -3.7% | 0.00% | -50.0% |
| Q3 2018 | $260,000 | -14.8% | 29,428 | -3.7% | 0.00% | 0.0% |
| Q2 2018 | $305,000 | +16.0% | 30,548 | +10.8% | 0.00% | 0.0% |
| Q1 2018 | $263,000 | -44.9% | 27,576 | -14.1% | 0.00% | -33.3% |
| Q4 2017 | $477,000 | -18.2% | 32,110 | +8.4% | 0.00% | -40.0% |
| Q3 2017 | $583,000 | +75.1% | 29,632 | +27.7% | 0.01% | +66.7% |
| Q2 2017 | $333,000 | +47.3% | 23,208 | -5.6% | 0.00% | +50.0% |
| Q1 2017 | $226,000 | -30.2% | 24,593 | -20.9% | 0.00% | -50.0% |
| Q4 2016 | $324,000 | +30.1% | 31,092 | +13.0% | 0.00% | +33.3% |
| Q3 2016 | $249,000 | +2.0% | 27,519 | -15.8% | 0.00% | 0.0% |
| Q2 2016 | $244,000 | -15.0% | 32,665 | +2.6% | 0.00% | -25.0% |
| Q1 2016 | $287,000 | -21.8% | 31,834 | +12.1% | 0.00% | 0.0% |
| Q4 2015 | $367,000 | +56.2% | 28,405 | +16.6% | 0.00% | +33.3% |
| Q3 2015 | $235,000 | -12.6% | 24,353 | -6.8% | 0.00% | -25.0% |
| Q2 2015 | $269,000 | +35.2% | 26,119 | +45.9% | 0.00% | +100.0% |
| Q1 2015 | $199,000 | +13.1% | 17,902 | +18.1% | 0.00% | 0.0% |
| Q4 2014 | $176,000 | – | 15,152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |